SCHEMBL24270752

SCHEMBL24270752

CCNC(=O)/C(=N\Nc1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.46
ALDH1A1 P00352 5/20 0.46
SMN1; SMN2 Q16637 3/20 0.43
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
TP53 P04637 1/20 0.43
GFER P55789 1/20 0.42
GAA P10253 7/20 0.42
KMT2A Q03164 4/20 0.42
LMNA P02545 3/20 0.42
HTT P42858 1/20 0.42
HPGD P15428 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
ATM Q13315 1/20 0.41
MEN1 O00255 3/20 0.40
RECQL P46063 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
POLB P06746 1/20 0.40
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2153952 0.80 SMN1; SMN2 (0.64) MAPTALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL2153944 0.80 SMN1; SMN2 (0.64) MAPTALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL13219034 0.78 MAPT (0.53) MAPTALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL11479747 0.78 POLB (0.51) MAPTALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL21283604 0.78 POLB (0.51) MAPTALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL10719307 0.78 POLB (0.51) MAPTALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL21283539 0.77 SMN1; SMN2 (0.69) MAPTALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL16232282 0.77 SMN1; SMN2 (0.69) MAPTALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL21283603 0.76 MAPT (0.45) MAPTALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL9917542 0.76 MAPT (0.53) MAPTALDH1A1SMN1; SMN2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11279677-B2 Photochromic hydrazone switches THE TRUSTEES OF DARTMOUTH COLLEGE (US) 2022-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11279677-B2 Photochromic hydrazone switches CRYZ, PIN1, PPOX MAPT 702/4885ALDH1A1 404/4885SMN1; SMN2 2545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.